Sugimoto, Keiki
Hayakawa, Fumihiko
Shimada, Satoko
Morishita, Takanobu
Shimada, Kazuyuki
Katakai, Tomoya
Tomita, Akihiro
Kiyoi, Hitoshi
Naoe, Tomoki
Article History
Received: 8 March 2015
Accepted: 13 July 2015
First Online: 17 August 2015
Competing interests
: T.N. received research funding from Otsuka Pharmaceutical Co. LTD., Bristol-Myers Squibb, Novartis Pharma, Chugai Pharmaceutical Co. LTD., Kyowa Hakko Kirin Co. LTD., Dainippon Sumitomo Pharma, Zenyaku Kogyo and FUJIFILM Corporation. K. Sugimoto is an employee of Otsuka Pharmaceutical Co., Ltd. H.K. received research funding from Bristol-Myers Squibb, Chugai Pharmaceutical Co. LTD., Kyowa Hakko Kirin Co. LTD., Dainippon Sumitomo Pharma, Zenyaku Kogyo and FUJIFILM Corporation. The other authors have no potential conflicts of interest.